Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-23-000828
Filing Date
2023-12-01
Accepted
2023-12-01 16:15:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13d-a.htm SC 13D/A 62943
  Complete submission text file 0000898432-23-000828.txt   64207
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 231459716
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Filed by) CIK: 0001738054 (see all company filings)

Type: SC 13D/A